Berry Global, PYLOTE to introduce Activated Rispharm multidose antimicrobial dropper for eye products at upcoming Pharmapack 2022 in Paris; Pylote's patented mineral technology--microspheres--is embedded into the resin masterbatch and is fully recyclable

May 11, 2022 (press release) –

The first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients.

Activated Rispharm™, the first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients, will be introduced at Pharmapack 2022 (18th & 19th May in Paris). Developed in a strategic commercial partnership between BERRY GLOBAL, a leading provider of innovative packaging and engineered products, and PYLOTE, a key player in the industrial mineral chemistry, the solution will be presented on the Berry Global stand (A60). Activated Rispharm™ will also be submitted into the 2022 Pharmapack Awards and will be seen at the exhibition’s Innovation Gallery.

Pylote’s patented mineral technology – microspheres – is embedded into the resin masterbatch, and is fully recyclable, thus supporting efforts towards sustainability.  

Activated Rispharm™ offers significant benefits including:

• Proven and certified antimicrobial mineral protection of dropper tip where over 85% of the contamination of the drops is found according to clinical study (Nentwich et al, Br J Ophthalmol 91(10): 1265-68).
• Proven and certified effectiveness against Adenovirus type 3 (conjunctivitis), Escherichia Coli and Staphylococcus aureus.
• Allows patients to have hygienic applications for every use with a multidose dropper.
• Reduces the amount of plastic waste by 16 times for one month treatment compared to monodose solutions.
• No change in patient treatment methods.
• Fully compliant, stable and biocompatible while certified non-irritant and non-cytotoxic technology (ISO10993:2010)
• No modifications required to packaging design or existing manufacturing/filling processes

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.